An investigation led by the province of New Brunswick has determined that environmental factors like herbicides and heavy metals are unlikely to be the cause of the reported neurological symptoms in hundreds of individuals. Dr. Yves Léger, the chief medical officer of health, presented the final report on the inquiry into 222 cases of “undiagnosed neurological illness.”
The investigation was initiated in response to concerns raised by Dr. Alier Marrero, a neurologist from Moncton, regarding elevated levels of herbicides, glyphosate, glufosinate, and various metals such as aluminum, arsenic, lead, and mercury in some patients. Dr. Léger stated that the findings do not indicate that exposure to specific environmental substances was a significant factor in the illness among the majority of the patients studied.
The report did not pinpoint the exact cause of the illness, which includes symptoms like muscle spasms, hallucinations, memory loss, and behavioral changes. However, Dr. Léger highlighted that previous reports and studies suggest that the patients likely have identifiable conditions such as Alzheimer’s disease and Lewy body dementia.
Patient representative Sarah Nesbitt shared that while some patients were disappointed by the lack of definitive answers, they found some solace in the acknowledgment of elevated levels of herbicides and heavy metals in a subset of patients. Dr. Léger acknowledged limitations in the data collected by Dr. Marrero, emphasizing the need for more accurate testing methods and follow-up procedures.
The report issued three recommendations for moving forward, including providing support for patients to receive independent assessments and diagnoses, conducting targeted testing for substances only when necessary, and implementing a formal review process by specialists for cases of undiagnosed neurological illness.
The provincial government has requested the Public Health Agency of Canada to review individual patient data to identify any potential trends or concerns. Patient advocates like Stacie Quigley-Cormier are hopeful that this review will shed light on the clusters of patients and environmental factors possibly contributing to the illness.
Dr. Léger emphasized the importance of addressing the patients’ suffering and ensuring they receive appropriate care. He deferred questions about Dr. Marrero’s actions to the regulatory bodies, emphasizing the need for a comprehensive approach to diagnosis and treatment in neurology.
Both the College of Physicians and Surgeons and Vitalité Health Network have committed to reviewing the report’s recommendations to determine any necessary actions. Patients will be kept informed throughout the process.